264 related articles for article (PubMed ID: 32102688)
1. Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.
Bao Q; Xu Y; Ding M; Chen P
Hereditas; 2020 Feb; 157(1):6. PubMed ID: 32102688
[TBL] [Abstract][Full Text] [Related]
2. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
Zhu LR; Yuan RX; Xia XB; Wang Y; Zhu YM; Fi L; Li J
Cancer Biomark; 2022; 33(1):71-82. PubMed ID: 34366325
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
[TBL] [Abstract][Full Text] [Related]
4. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
5. Combination of DNA ploidy analysis and miR-21 or miR-24 in screening malignant pleural effusion.
Liu C; Huang L; Zhang X; Yang J
Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):376-381. PubMed ID: 29069463
[TBL] [Abstract][Full Text] [Related]
6. S100A2: A potential biomarker to differentiate malignant from tuberculous pleural effusion.
Wang T; Wang N; Zhang L; Liu Y; Thakur A
Indian J Cancer; 2021; 58(2):241-247. PubMed ID: 33402562
[TBL] [Abstract][Full Text] [Related]
7. Label-Free Quantitative Proteomics Identifies Novel Biomarkers for Distinguishing Tuberculosis Pleural Effusion from Malignant Pleural Effusion.
Pan L; Zhang X; Jia H; Huang M; Liu F; Wang J; Du B; Wei R; Sun Q; Xing A; Li Q; Zhang Z
Proteomics Clin Appl; 2020 Jan; 14(1):e1900001. PubMed ID: 31715074
[TBL] [Abstract][Full Text] [Related]
8. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicle MicroRNA in Malignant Pleural Effusion.
Shojaee S; Romano G; Sanchez TM; Yermakhanova G; Saviana M; Le P; Nigita G; Calore F; Guthrie R; Hess K; Kang L; Swift-Scanlan T; Graham JT; Rahman NM; Nana-Sinkam PS; Acunzo M
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421832
[TBL] [Abstract][Full Text] [Related]
10. Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.
Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Feng J; Li X; Mo B
J Clin Lab Anal; 2022 Aug; 36(8):e24579. PubMed ID: 35819097
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion.
Shin YM; Yun J; Lee OJ; Han HS; Lim SN; An JY; Lee KH; Lee KM; Choe KH
Cancer Res Treat; 2014 Apr; 46(2):178-85. PubMed ID: 24851110
[TBL] [Abstract][Full Text] [Related]
12. Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion.
Tamiya H; Mitani A; Saito A; Ishimori T; Saito M; Isago H; Jo T; Yamauchi Y; Tanaka G; Nagase T
Anticancer Res; 2018 Dec; 38(12):6707-6714. PubMed ID: 30504380
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion.
Shao MM; Pei XB; Chen QY; Wang F; Wang Z; Zhai K
Front Immunol; 2023; 14():1161375. PubMed ID: 37143656
[TBL] [Abstract][Full Text] [Related]
14. High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion.
Yi F; Zhang X
Medicine (Baltimore); 2019 Sep; 98(38):e17253. PubMed ID: 31567996
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
16. Exosomal miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis.
Zhang X; Bao L; Yu G; Wang H
Front Surg; 2022; 9():1050242. PubMed ID: 36684253
[TBL] [Abstract][Full Text] [Related]
17. [Level of soluble programmed death ligand 1 in pleural effusion and peripheral blood of patients with tuberculous pleural effusion and its clinical implications].
Pan X; Xing Y; Shi M; Zhou T; Qian B; Chen Y
Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1543-6. PubMed ID: 25146741
[TBL] [Abstract][Full Text] [Related]
18. Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion.
Yang Y; Ma L; Qiao X; Zhang X; Dong SF; Wu MT; Zhai K; Shi HZ
Transl Lung Cancer Res; 2020 Aug; 9(4):1247-1257. PubMed ID: 32953502
[TBL] [Abstract][Full Text] [Related]
19. Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion.
Chen KY; Feng PH; Chang CC; Chen TT; Chuang HC; Lee CN; Su CL; Lin LY; Lee KY
Int J Gen Med; 2016; 9():183-9. PubMed ID: 27354819
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.
Gao J; Song L; Li D; Peng L; Ding H
Medicine (Baltimore); 2019 Oct; 98(42):e17416. PubMed ID: 31626097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
